歌礼制药有限公司（01672）于2025年12月19日发布翌日披露报表，公告当日通过香港交易所回购股份200,000股，约占当日已发行股本的0.0202%。此次回购的价格区间为每股12.39港元至12.99港元，总对价约2,558,560港元。
根据公告，截至2025年12月19日，公司已发行股本仍为991,874,320股，库藏股数量为7,084,210股。公司回购授权决议于2025年5月22日获得通过，最多可回购96,284,628股。至今，公司已合计回购5,386,000股股份，占授权通过当日总股本的0.5589%。
公司同时确认，此次交易已遵守香港联合交易所有限公司证券上市规则及其他适用规例，公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.